FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

2,253 letters match. Newest first.

  1. Hearthy Foods, Inc.

    FDA cited Hearthy Foods after an inspection for CGMP violations in RTE whey protein and dietary supplements, including allergen and pest issues.

    High risk
  2. Intelligent Remedies, Inc.

    FDA warned Intelligent Remedies that disease-treatment claims make nine products unapproved new drugs.

    High risk
  3. Diamond-Herpanacine of PA, Inc.

    FDA says Diamond-Herpanacine supplement claims make its eye and skin products unapproved drugs.

    Low
  4. Supersmart USA, LLC

    FDA says Supersmart USA sold dietary supplements with disease-treatment claims, making them unapproved and misbranded drugs.

    Low
  5. Foshan Miwei Cosmetics Co., Ltd.

    FDA warns Foshan Miwei Cosmetics over manufacturing practice failures and unapproved, misbranded over-the-counter (OTC) sunscreen drugs; drugs on import alert.

    High risk
  6. Nupack Inc.

    FDA warned Nupack Inc. that its dietary supplements were unapproved drugs and made without required manufacturing-practice records.

    High risk
  7. Daily Manufacturing Solutions Inc.

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  8. nicoprof.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  9. New Life Pharma LLC

    New Life Pharma made unapproved semaglutide and tirzepatide sterile vials without sterility controls and refused FDA access to some areas.

    High risk
  10. Pro Numb Tattoo Numbing Spray, LLC

    FDA cited Pro Numb Tattoo Numbing Spray for selling unapproved, misbranded numbing drugs and manufacturing quality failures after a November 2025 inspection.

    High risk
  11. shopcalismokes.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  12. vapepengood.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  13. Thrive Health and Wellness, LLC dba Thrive Health Solutions

    FDA warned Thrive Health and Wellness, a Colorado repackager, that sterile drugs were made in unsanitary conditions and sold without approval.

    High risk
  14. Smart Vending Services, LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  15. Chemco Corporation

    FDA warns Chemco Corporation about CGMP failures and unapproved, misbranded OTC drug products from its Miami Lakes facility.

    High risk
  16. mohawksmoke.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  17. Beauty of Aztlan LLC

    FDA warns Beauty of Aztlan it sells unapproved, misbranded injectable botulinum toxin drugs online to U.S. consumers.

    High risk
  18. Dry Springs Pharmacy

    FDA warned Dry Springs Pharmacy that its website sells unapproved and misbranded opioids, benzodiazepines, and stimulants to U.S. consumers.

    High risk
  19. Online Rx Medz

    FDA warns Online Rx Medz for selling unapproved, illegally labeled opioids, benzodiazepines, and stimulants online.

    High risk
  20. Rxgoodusa

    FDA warned Rxgoodusa that its website sells unapproved, misbranded opioid and benzodiazepine drugs to U.S. consumers without prescriptions.

    High risk
  21. Half Hill Farm Inc.

    FDA cited Half Hill Farm's mushroom extracts as unapproved new drugs over website disease-treatment claims.

    Low
  22. Global Tobacco, LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  23. buydeltas.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  24. matesbrand.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  25. 4U Health

    FDA says 4U Health sells an unapproved HIV dried blood spot self-collection kit, making it adulterated and misbranded.

    High risk
  26. ImmunityBio, Inc.

    FDA says ImmunityBio's Anktiva TV ad and podcast falsely claim it can cure or prevent all cancers.

    High risk
  27. prilla.com/us

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  28. Citra100mg

    FDA warns Citra100mg it sells unapproved, misbranded tramadol opioids without prescriptions to U.S. consumers online.

    High risk
  29. SSS AUSTAR LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  30. thesnuslife.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  31. snushaven.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  32. idripejuice.com

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  33. Premium Health Management Inc. dba Premium Health

    FDA warns Premium Health over misleading website claims for compounded semaglutide and tirzepatide.

    Low
  34. Zeuss LLC dba Zeuss

    FDA warned telehealth seller Zeuss that its website misbrands compounded tirzepatide by implying Zeuss makes it and that it is FDA-approved.

    Medium
  35. Lean Rx, Inc. dba SkinnyRx

    SkinnyRx's website misbranded compounded semaglutide and tirzepatide by wrongly suggesting it makes the drugs and that they are FDA-approved.

    Low
  36. Kare Solutions, LLC dba Zappy

    FDA warned Zappy that its website falsely suggested it compounds semaglutide, tirzepatide, and liraglutide and made misleading approval-like claims.

    Low
  37. Strut Health, LLC dba Strut

    FDA says Strut Health's website falsely labeled compounded semaglutide and tirzepatide as its own and FDA-approved.

    Low
  38. Refills Health, LLC dba Refills Health

    FDA told telehealth seller Refills Health its website misbrands compounded semaglutide by implying FDA approval and naming itself as maker.

    Medium
  39. Weightless Medical LLC dba WeightCare

    FDA warned telehealth seller WeightCare that its website falsely presents it as the compounder of semaglutide and tirzepatide drugs.

    Low
  40. Viv Health, Inc. dba VIV RX

    FDA warned telehealth company VIV RX that its website falsely suggests it compounds semaglutide and tirzepatide, making the drugs misbranded.

    Medium
  41. Peaks Curative, LLC dba Peaks

    FDA warned Peaks Curative over false or misleading website claims for compounded (pharmacy-made) semaglutide, including implied FDA approval.

    Low
  42. PharmaZee

    FDA warns PharmaZee over misleading website claims for compounded semaglutide and tirzepatide, including implying PharmaZee compounds them and that they are proven.

    Low
  43. Good Girl LLC dba GoodGirlRX

    FDA warns telehealth seller GoodGirlRX that its website misbrands compounded semaglutide and tirzepatide, claiming FDA approval and implying it is the compounder.

    Medium
  44. Ivim Services LLC dba Ivim

    FDA says Ivim's telehealth website mislabels compounded semaglutide and tirzepatide as Ivim-made when it is not the compounder.

    Low
  45. Join Josie

    FDA says Join Josie's website misbranded compounded semaglutide and tirzepatide by falsely implying FDA approval and naming Join Josie as compounder.

    Low
  46. Kin Meds

    FDA warned Kin Meds over false claims for compounded semaglutide and tirzepatide, including implying it is the compounder and that products are approved.

    Low
  47. Levity Inc. dba Levity

    FDA warned Levity over misleading website claims for compounded semaglutide and liraglutide, including implying Levity made the drugs and that they were FDA-approved.

    Low
  48. MaxLife Technologies Inc. dba Maxlife

    FDA told telehealth seller Maxlife its website falsely implied Maxlife compounds semaglutide and tirzepatide and that the drugs are FDA-approved.

    Medium
  49. Better Health Labs, Inc. dba Measured

    FDA warned telehealth seller Measured its website misbranded compounded semaglutide and tirzepatide by implying it made them and that they were FDA-approved.

    Medium
  50. MEDVi, LLC dba MEDVi

    FDA says telehealth seller MEDVi misbranded compounded semaglutide and tirzepatide by implying MEDVi makes them and that they are FDA-approved.

    Medium